Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Chang

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Molecular Cell|October 13, 2009
The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineriesZhe Sha, Laurence M Brill, Rodrigo Cabrera, et al.
Epilepsia|February 8, 2012
An intraoperative multimodal neurophysiologic approach to successful resection of precentral gyrus epileptogenic lesionsMirela V Simon, Andrew J Cole, Eric C Chang, et al.
Cell & Bioscience|March 17, 2015
Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cellsJinfeng Suo, Daniel Medina, Sabrina Herrera, et al.
Breast Cancer Research : BCR|October 18, 2022
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasivenessZe-Yi Zheng, Hanan Elsarraj, Jonathan T Lei, et al.
Nature Communications|August 8, 2014
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancersJamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao, et al.
Cell Reports|July 14, 2015
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 ActivationZe-Yi Zheng, Lin Tian, Wen Bu, et al.
Science Translational Medicine|August 27, 2025
NF1-depleted ER<sup>+</sup> breast cancers are differentially sensitive to CDK4/6 inhibitorsZe-Yi Zheng, Anran Chen, Eric J Jaehnig, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2026
Rat somatic genome editing enables ER+ breast cancer modelingWen Bu, Tobie D Lee, Meenakshi Anurag, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Cancer Research Communications|July 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Cell|October 13, 2009
The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineriesZhe Sha, Laurence M Brill, Rodrigo Cabrera, et al.
Epilepsia|February 8, 2012
An intraoperative multimodal neurophysiologic approach to successful resection of precentral gyrus epileptogenic lesionsMirela V Simon, Andrew J Cole, Eric C Chang, et al.
Cell & Bioscience|March 17, 2015
Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cellsJinfeng Suo, Daniel Medina, Sabrina Herrera, et al.
Breast Cancer Research : BCR|October 18, 2022
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasivenessZe-Yi Zheng, Hanan Elsarraj, Jonathan T Lei, et al.
Nature Communications|August 8, 2014
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancersJamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao, et al.
Cell Reports|July 14, 2015
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 ActivationZe-Yi Zheng, Lin Tian, Wen Bu, et al.
Science Translational Medicine|August 27, 2025
NF1-depleted ER<sup>+</sup> breast cancers are differentially sensitive to CDK4/6 inhibitorsZe-Yi Zheng, Anran Chen, Eric J Jaehnig, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2026
Rat somatic genome editing enables ER+ breast cancer modelingWen Bu, Tobie D Lee, Meenakshi Anurag, et al.
Cancer Letters|May 30, 2026
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasisZifan Zhao, Ze-Yi Zheng, Jonathan T Lei, et al.
Cancer Research Communications|July 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei, et al.
Pageof 4